New Key Statistics Module, Z-Score and F-Score
SZSE:002349 Key Ratios
Market Cap ¥ M | 6,496.18 |
Enterprise Value ¥ M | 5,076.49 |
P/E(ttm) | 30.42 |
PE Ratio without NRI | 30.07 |
Forward PE Ratio | -- |
Price/Book | 2.59 |
Price/Sales | 4.56 |
Price/Free Cash Flow | 26.76 |
Price/Owner Earnings | 43.55 |
Payout Ratio % | 0.34 |
Revenue (TTM) ¥ M | 1,437.00 |
EPS (TTM) ¥ | 0.27 |
Beneish M-Score | -2.54 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | 5.70 |
EV-to-EBIT | 16.89 |
EV-to-EBITDA | 16.89 |
PEG | -- |
Shares Outstanding M | 814.18 |
Net Margin (%) | 15.07 |
Operating Margin % | 18.69 |
Pre-tax Margin (%) | 20.73 |
Quick Ratio | 5.81 |
Current Ratio | 6.77 |
ROA % (ttm) | 6.80 |
ROE % (ttm) | 8.64 |
ROIC % (ttm) | 13.37 |
Dividend Yield % | 1.17 |
Altman Z-Score | 13.24 |
SZSE:002349 Number of Guru Trades
SZSE:002349 Volume of Guru Trades
Gurus Latest Trades with SZSE:002349
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:002349 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Jinghua Pharmaceutical Group Co Ltd Insider Transactions
No Available Data